1999;18:4948\4957. both in vitro and in vivo. CD146 is expressed by 4 cell lines and by most of primary tumors at any stage. Short hairpin RNA\mediated knockdown of CD146, or treatment with an anti\CD146 polyclonal antibody, effectively inhibited growth of neuroblastoma cells both in vitro and in vivo, principally due to increased apoptosis via the focal adhesion kinase and/or nuclear factor\kappa B signaling pathway. Furthermore, the anti\CD146 polyclonal antibody markedly inhibited tumor growth in immunodeficient mice inoculated with primary neuroblastoma cells. In conclusion, CD146 represents a promising therapeutic target for neuroblastoma. Keywords: antibody, apoptosis, CD146, focal adhesion kinase, neuroblastoma NMS-873 Targeting CD146 inhibits in vitro proliferation of neuroblastoma (NB) cells and in vivo growth of NB tumors. Exposure of NB cells to the anti\CD146 antibody led to a significant reduction in survival and anchorage\independent growth. Intraperitoneal injection of the anti\CD146 antibody into immunodeficient mice for ~50?d led to a significant inhibition of tumor growth. AbbreviationsAADAmino\actinomycin DADCCantibody\dependent cellular cytotoxicityAPCallophycocyaninCIconfidence intervalFAKfocal adhesion kinaseLucluciferaseMCAMmelanoma cell adhesion moleculeMFImean fluorescence intensityNBneuroblastomaNCneural crestNF\Bnuclear factor\kappa BNOGNOD/Shi\scid IL\2R\nullOSoverall survivalPEphycoerythrinPFSprogression\free survivalShshort hairpinTARGETTherapeutically Applicable Research to Generate Effective Treatment 1.?INTRODUCTION Neuroblastoma is the most common extracranial solid tumor of childhood, accounting for ~15% of cancer\related deaths in pediatric patients under the age of 15?y. 1 The disease is highly heterogenous, with prognoses ranging from spontaneous regression without treatment to a dismal end result. Risk\stratified treatment based on clinicopathological (ie, age at analysis, stage, and histology) and genetic (ie, MYCN amplification and ploidy) prognostic factors has led to a designated improvement in end result for individuals with low\risk or intermediate\risk NB. However, the prognosis for those with high\risk, recurrent, or refractory NB remains dismal, despite rigorous multimodality therapy. 2 , 3 In addition, long\term NB survivors are at NMS-873 risk of developing late adverse effects such as renal impairment, endocrine disturbance, dental problems, and secondary malignancies. 4 Individuals with minimal residual disease can be treated with an anti\GD2 monoclonal antibody, with significant medical benefit. 5 However, this therapy remains unsatisfactory for individuals with measurable tumors. 6 Consequently, more effective and less harmful therapies are warranted. NB is thought to originate from NC\derived immature cells. NC is definitely a transient human population of multipotent progenitors that occurs in the neural plate border in vertebrate embryos before migrating throughout the body to generate various cells, including bones, neurons, glia, and melanocytes. 7 CD146 (melanoma cell adhesion molecule [MCAM]) is definitely a cell adhesion molecule belonging to the immunoglobulin superfamily. The gene is located on chromosome 11q23.3. 8 In adults, manifestation of CD146 is restricted to a limited number of normal cells, Rabbit Polyclonal to CPA5 including endothelium, clean muscle mass, ganglion cells, Schwann cells, cerebellar cortex, and triggered NMS-873 T lymphocytes. 9 , 10 , 11 By contrast, it is indicated widely in embryonic cells, including NC and its derivatives. 12 CD146 plays an active role in a variety of process, including in cell\cell and cell\matrix relationships, cell migration, transmission transduction, immune reactions, and embryonic development. 10 Growing evidence has shown that CD146 encourages tumor progression and metastasis, and is a encouraging candidate for immunotherapy in various malignancies, including NC\derived melanoma, malignant rhabdoid tumor, and NB. 11 , 13 , 14 , 15 , 16 However, the potential of CD146 like a restorative target for NB remains unclear. Here, we examined the manifestation of CD146 by NB NMS-873 cell lines and in medical samples and investigated the anti\tumor effects of CD146\focusing on treatment for NB cells both in vitro and in vivo. NMS-873 2.?MATERIALS AND METHODS 2.1. Cell lines, tumor samples, and animals Human being NB cell lines (IMR\32, SK\N\SH, RT\BM1, and SK\N\SIFA), founded as reported previously,.